Article
Fluoroquinolone-resistant Escherichia coli sequence type 131 isolates causing bloodstream infections in a canadian region with a centralized laboratory system: rapid emergence of the H30-Rx sublineage.
Antimicrobial agents and chemotherapy - 1 May 2014
Peirano Gisele, Pitout Johann D D
Abstract excerpt
A population-based surveillance study was designed to describe the clinical features and characteristics of sequence type 131 (ST131) and its H30 and H30-Rx sublineages among fluoroquinolone-resistant (FQ-R) Escherichia coli isolates that caused bloodstream infections (BSIs) in a Canadian region with a centralized laboratory system over an 11-year period (2000 to 2010). Nonrepeat isolates from true incident cases...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
